Conquer Cancer through AI. Lunit is a public company that develops medical AI software for cancer screening and treatment. Lunit AI can empower you to enhance diagnostic performance. Our AI for chest x-ray and 2D & 3D mammography has been validated through 100+ publications in peer-reviewed journals such as JAMA Oncology, Lancet Digital Health and Radiology, and is now in use in 3,500+ sites globally. < Lunit AI Suite for Radiology > • Lunit INSIGHT CXR, AI Solution for Chest X-ray • Lunit INSIGHT MMG, AI Solution for Mammography • Lunit INSIGHT DBT, AI Solution for Digital Breast Tomosynthesis • Lunit CXR Triage, AI solution for Chest X-ray Triage *emergency department use, available in the US only *If you are interested in Lunit Oncology, please visit Lunit Oncology’s LinkedIn page.
我们正在追踪 Lunit Cancer Screening 的市场扩张
最近 90 天内有 21 个信号。
Lunit Cancer Screening 的国际扩张与竞争对手的对比情况
Lunit Cancer Screening你条形图显示所对比公司之间的相对规模。
列5| 公司 | 市场 | 新市场 | 势头 | 活动 | 扩张评分 |
|---|---|---|---|---|---|
 Lunit Cancer Screening你 | 0 | 0 | — | 0 | 0 |
(Seoul) Senior AX Engineer
查看职位Seoul, Seoul, South Korea · Full-time · 3天前
(Global) Technical Service Engineer · Japan
查看职位Tokyo, Tokyo, Japan · 4天前
(Global) Director, Clinical Deployment & Growth - Lunit SCOPE
查看职位North Carolina, United States · 4天前
AI-powered chest X-ray analysis for faster, more accurate diagnoses
进行中
L’IA au service des radiologues pour un dépistage du cancer du sein fiable
已结束
RSNA 2025: Measuring the Clinical Impact of AI in 3D Breast Imaging
已结束Lunit因衍生金融负债评估收益面临股价困境。公司计划通过2500亿韩元供股解决可转债提前赎回问题，但会计问题仍未解决。
Lunit在2026年欧洲放射学大会上发表21项研究成果，展示乳房X光摄影、胸部X光分析和乳房密度量化的AI解决方案。
Lunit将在AACR 2026展示六项AI生物标志物平台研究，展示癌症研究和治疗预测的进展。
解锁已验证邮箱与直拨电话
免费 · 无需信用卡
关于 Lunit Cancer Screening 的业务、市场和增长信号的快速解答。
